On April 5, 2017, CSI Specialty Group released episode 51 of “The Specialty Pharmacy Podcast.” This episode featured Dr. Gordon J. Vanscoy, PANTHERx® Specialty Pharmacy...

PANTHERx will dispense KISQALI® (ribociclib) as a first-line treatment for postmenopausal women with an advanced form of breast cancer. The Food and Drug Administration has...

We are proud to announce that Specialty Pharmacy Times and Zitter Health Insights have selected PANTHERx® as a finalist in the Non-PBM/Payer Specialty Pharmacy category....

PANTHERx Specialty Pharmacy is proud to announce that it is actively pursuing a third Specialty Pharmacy Accreditation through the Center for Pharmacy Practice Accreditation (CPPA)....

2016 was quite a year for PANTHERx Specialty Pharmacy. Check out our infographic for a quick rundown of our “Top 5 Moments of 2016.”  

Last month, the Master of Science in Pharmacy Business Administration (MSPBA) program graduated its first class in its new, one-of-a-kind Master’s program. Created to help meet...

We’re excited to announce the PANTHERx Specialty Pharmacy Fellowship Program! The program starts on July 1, 2017 and lasts until June 30, 2018. The deadline for...

Over the last few weeks, PANTHERx® Specialty Pharmacy has teamed with the Consortium for Public Education to provide students with the opportunities to apply STEAM (Science, Technology,...

PANTHERx® Specialty Pharmacy’s Chairman and CEO Dr. Gordan J. Vanscoy was featured earlier this month in the Pittsburgh Business Times as part of their “CEO...

As part of PANTHERx®’s commitment to our value of “Authentic Dedication,” we are proud to announce that we are sponsoring the first annual “Hole” Lot...